Kyla E. Driscoll
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 1
- CAR-T cell therapy research 1
- Chemokine receptors and signaling 1
-
- Immune cells in cancer 3
- Co-authors
- Karim Adnane Benhadji (3 shared papers)Ivelina Gueorguieva (2 shared papers)Ann Cleverly (2 shared papers)Shawn T. Estrem (2 shared papers)Durisala Desaiah (1 shared paper)Susan C. Guba (1 shared paper)J. Scott Sawyer (1 shared paper)Michael M. F. Lahn (1 shared paper)
- Journals
- Cancers (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Oncotarget (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Kyla E. Driscoll
12 papers receiving 1.3k citations
Kyla E. Driscoll's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 723
- Immunology 370
- Cancer Research 185
- Molecular Biology 548
- Immunology and Allergy 37
Countries citing papers authored by Kyla E. Driscoll
This map shows the geographic impact of Kyla E. Driscoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyla E. Driscoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyla E. Driscoll more than expected).
Fields of papers citing papers by Kyla E. Driscoll
This network shows the impact of papers produced by Kyla E. Driscoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyla E. Driscoll. The network helps show where Kyla E. Driscoll may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyla E. Driscoll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway Hit paper breakdown → | 2015 | 493 |
| 2 | 2018 | 287 | |
| 3 | 2017 | 154 | |
| 4 | 2019 | 87 | |
| 5 | 2017 | 86 | |
| 6 | 2018 | 79 | |
| 7 | 2019 | 76 | |
| 8 | 2016 | 17 | |
| 9 | 2021 | 16 | |
| 10 | 2018 | 8 | |
| 11 | 2021 | 8 | |
| 12 | 2019 | 5 |
About Kyla E. Driscoll
Kyla E. Driscoll is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 12 papers that have together received 1.3k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers), Cancer Cells and Metastasis (1 paper), CAR-T cell therapy research (1 paper), Cytomegalovirus and herpesvirus research (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Oncology (723 citations), Immunology (370 citations), Cancer Research (185 citations), Molecular Biology (548 citations) and Immunology and Allergy (37 citations). Kyla E. Driscoll has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Karim Adnane Benhadji, Ivelina Gueorguieva, Ann Cleverly, Shawn T. Estrem, Durisala Desaiah, Susan C. Guba, J. Scott Sawyer, Michael M. F. Lahn, Stephan Herbertz and Christopher A. Slapak. Their work appears in journals such as Cancers, Cancer Chemotherapy and Pharmacology, Journal for ImmunoTherapy of Cancer, Oncotarget and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.